Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The landscape of gene mutations in cirrhosis and hepatocellular carcinoma
Miryam Müller, Thomas G. Bird, Jean–Charles Nault
Journal of Hepatology (2020) Vol. 72, Iss. 5, pp. 990-1002
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Single‐cell RNA sequencing in cancer research
Yijie Zhang, Dan Wang, Peng Miao, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 257
Hepatocellular carcinoma: old friends and new tricks
Eunsun Kim, Patrick Viatour
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 12, pp. 1898-1907
Open Access | Times Cited: 237
Modern therapeutic approaches for the treatment of malignant liver tumours
Henrik Petrowsky, Ralph Fritsch, Matthias Gückenberger, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 12, pp. 755-772
Closed Access | Times Cited: 185
Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies
Julie Giraud, Domitille Chalopin, Jean‐Frédéric Blanc, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 174
Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy
Ling Yu, Zhenjie Wang, Zhuomao Mo, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 7, pp. 2004-2015
Open Access | Times Cited: 136
Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma
Deniz Tümen, Philipp Heumann, Karsten Gülow, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3202-3202
Open Access | Times Cited: 94
Molecular mechanisms in MASLD/MASH-related HCC
Xiaobo Wang, Liang Zhang, Bingning Dong
Hepatology (2024)
Closed Access | Times Cited: 45
Human-correlated genetic models identify precision therapy for liver cancer
Miryam Müller, Stephanie May, H. G. HALL, et al.
Nature (2025)
Open Access | Times Cited: 2
Liver Inflammation and Hepatobiliary Cancers
Valentina Leone, Adnan Ali, Achim Weber, et al.
Trends in cancer (2021) Vol. 7, Iss. 7, pp. 606-623
Closed Access | Times Cited: 61
The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications
Muhammad Sajid, Lianxin Liu, Cheng Sun
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 48
Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4286-4286
Open Access | Times Cited: 32
PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma
Fei Song, Chenggui Wang, Jiazhen Mao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma
Peng Tian, Fang Sun, Jia-Chun Yang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 19, pp. 2575-2602
Open Access | Times Cited: 15
Evolving global etiology of hepatocellular carcinoma (HCC): Insights and trends for 2024.
Abraham Koshy
Journal of Clinical and Experimental Hepatology (2024) Vol. 15, Iss. 1, pp. 102406-102406
Closed Access | Times Cited: 15
Differential Effects of Genetic Polymorphism on Comorbid Disease in Metabolic Dysfunction–Associated Steatotic Liver Disease
Yuya Seko, Kanji Yamaguchi, Toshihide Shima, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 7, pp. 1436-1443.e4
Closed Access | Times Cited: 9
Exploring liver cancer biology through functional genetic screens
Cun Wang, Ying Cao, Chen Yang, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 10, pp. 690-704
Closed Access | Times Cited: 45
Specificity and off-target effects of AAV8-TBG viral vectors for the manipulation of hepatocellular gene expression in mice
Christos Kiourtis, Ania Wilczynska, Colin Nixon, et al.
Biology Open (2021) Vol. 10, Iss. 9
Open Access | Times Cited: 42
Genetic variation inTERTmodifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study
Stephan Buch, Hamish Innes, Philipp Lutz, et al.
Gut (2022) Vol. 72, Iss. 2, pp. 381-391
Open Access | Times Cited: 34
A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma
Yue Li, Huanye Mo, Shengli Wu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 32
The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma
Cunjie Chang, Muthukumar Rajasekaran, Yiting Qiao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 31
The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression
Irene Peñuelas‐Haro, Rut Espinosa‐Sotelo, Eva Crosas‐Molist, et al.
Hepatology (2022) Vol. 78, Iss. 2, pp. 416-433
Open Access | Times Cited: 30
The greater impact of PNPLA3 polymorphism on liver‐related events in Japanese non‐alcoholic fatty liver disease patients: A multicentre cohort study
Yuya Seko, Kanji Yamaguchi, Toshihide Shima, et al.
Liver International (2023) Vol. 43, Iss. 10, pp. 2210-2219
Open Access | Times Cited: 22
3D Bioprinting: An Important Tool for Tumor Microenvironment Research
Yilin Li, Jiaxing Liu, Shun Xu, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 8039-8057
Open Access | Times Cited: 19
Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF‐α signaling
Dandan Qi, Min Lu, Pengfei Xu, et al.
Cancer Communications (2023) Vol. 43, Iss. 12, pp. 1354-1372
Open Access | Times Cited: 17
CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer
Yanfeng Liu, Fan Wang, Guoquan Yan, et al.
Cancer Letters (2024) Vol. 595, pp. 217006-217006
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top